Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study — Ching‐Lung Cheung (2021) | RDL Network
Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study
Article 2021 en
Authors
CC
Ching‐Lung Cheung
CS
Chor‐Wing Sing
WL
Wallis C. Y. Lau
Abstract
1 min read
Among adults with AF receiving OACs, the use of dabigatran had the lowest risk of diabetes when compared with warfarin use.
Wallis C. Y. Lau, Esther W. Chan, Ching‐Lung Cheung, Chor‐Wing Sing, Kenneth K. C. Man, Professor Gregory Lip, Chung‐Wah Siu, Joanne K.Y. Lam, Alan C.H. Lee, Ian Chi Kei Wong
Steven Deitelzweig, Allison Keshishian, A Kang, Aaron Jenkins, Nipun Atreja, Patricia Schuler, Jenny Jiang, K Lovett, Hüseyin Yüce, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.